NEUROLOGISCHE REIZLEITUNGSANKER

Patent europeic · EP4100110 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4100110
Numer da la dumonda
EP21750316
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
27-01-2021
Publitgà
14-12-2022
Concedì
30-09-2026
La protecziun finescha il pli tard
26-01-2041
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61N 1/05 (2006.01)
A61N 1/36 (2006.01)
A61B 17/28 (2006.01)
Prioritad
US 202016780502 03.02.2020
Dumonda PCT
PCT/US2021/015279 27.01.2021
Publicaziun PCT
WO2021/158408 12.08.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 30-09-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 30.09.2026

Partidas

Possessur

Nevro Corporation

1800 Bridge Parkway, Redwood City, CA 94065, US

Inventur

WONG, Mark, Steven

Redwood City, CA 94065, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.